• How NINJ1 Rings Drive Plasma Membrane Rupture

  2026-08-29

  The reference study proposes that NINJ1 promotes plasma membrane rupture by assembling into membrane-associated, nanodisc-like rings rather than acting only as a conventional adhesion protein. Combining cryo-EM, liposome reconstitution, live-cell imaging, and super-resolution microscopy, the authors distinguish NINJ1 from NINJ2 and connect ring formation with inflammasome-associated cell lysis.

• PreScission Protease (PSP): Tag Cleavage Guide

  2026-08-28

  PreScission Protease (PSP), SKU K1101, provides sequence-directed removal of compatible affinity tags from recombinant fusion proteins while supporting cold purification workflows. It is appropriate when the target construct contains an accessible HRV 3C protease cleavage site, but it should not be treated as a universal protease for proteins lacking the required sequence or for workflows with unvalidated buffer compatibility.

• BAPTA: Causal Calcium Signaling in Cell Assays

  2026-08-28

  BAPTA is a high-affinity calcium chelator for testing whether intracellular Ca2+ changes drive apoptosis and pathway activation. This article presents a causal-inference framework grounded in recent IP3R/Ca2+/STAT3 toxicology research, with assay controls, interpretation guidance, and product-handling considerations.

• Tivozanib (AV-951) Assay Workflow Guide

  2026-08-27

  Tivozanib (AV-951) gives oncology researchers a highly selective way to interrogate VEGFR signaling, angiogenesis-related phenotypes, and combination responses. This guide translates its potency and solubility profile into practical dose–response, viability, apoptosis, and troubleshooting workflows.

• Ciprofloxacin Hydrochloride: From Target to Translation

  2026-08-27

  Ciprofloxacin hydrochloride is more than a familiar fluoroquinolone antibiotic: it is a mechanistically defined research tool for studying bacterial DNA replication, immune signaling, and cell-fate responses. This thought-leadership guide connects its validated antibacterial role with emerging anti-parasitic evidence while defining the controls, limitations, and translational decisions needed to move beyond a conventional product-page view.

• Individual SGLT2 Inhibitors in T2D and Heart Failure

  2026-08-26

  This systematic review and network meta-analysis compared five SGLT2 inhibitors in 20,438 patients with type 2 diabetes and heart failure, separating class-wide effects from possible differences between individual drugs. All agents reduced heart failure hospitalization, whereas the composite of cardiovascular death or hospitalization showed a less uniform pattern, providing a more cautious framework for interpreting ertugliflozin evidence.

• Reversine: Practical Aurora Kinase Inhibitor Guide

  2026-08-26

  Reversine (SKU A3760) is a research small molecule for probing Aurora kinase-dependent mitotic regulation, cell-cycle disruption, and related cancer phenotypes. This guide covers stock preparation, assay controls, and interpretation boundaries; it is intended for laboratory research only, not diagnosis, treatment, or clinical use.

• Oligo (dT) 25 Beads: Practical mRNA Purification

  2026-08-25

  Oligo (dT) 25 Beads support selective eukaryotic mRNA isolation from total RNA or animal and plant cell or tissue preparations through polyA tail mRNA capture. They are not a universal total-RNA cleanup reagent and are unsuitable when the target RNA lacks a polyadenylated tail.

• PERK-Dependent Pyroptosis in Disc Degeneration

  2026-08-25

  This study identifies a mechanistic link between unresolved endoplasmic reticulum stress and pyroptosis in nucleus pulposus cells, placing the PERK/eIF2α/ATF4 axis upstream of JAK1–STAT3 activation. Its findings clarify how ER stress may amplify inflammatory cell death during intervertebral disc degeneration and provide a rationale for testing pathway-specific interventions.

• Ginsenoside Rg1 and Anesthesia-Induced Neuroimmune Injury

  2026-08-24

  A 2025 Journal of Ethnopharmacology study shows that Ginsenoside Rg1 reduces behavioral, inflammatory, synaptic, and intestinal abnormalities caused by prolonged isoflurane anesthesia in mice. Its key mechanistic contribution is evidence that regulatory T cells are required for restoring the gut-immune-brain axis, although translation beyond this preclinical model remains uncertain.

• Bestatin (Ubenimex): Aminopeptidase Inhibitor Guide

  2026-08-24

  Bestatin, also called Ubenimex, is a research inhibitor of aminopeptidase B, leucine aminopeptidase, aminopeptidase N, and related cytosolic aminopeptidases. Its reported nanomolar-to-micromolar IC50 values support aminopeptidase activity measurement, apoptosis assay design, multidrug resistance (MDR) research, and cancer research, but assay conditions and translational limits must be defined.

• Astrocytic GAT-3 in Dentate Gyrus Memory

  2026-08-23

  The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than a passive GABA-clearance mechanism. By linking GABA uptake to astrocytic Ca2+ signaling, presynaptic GluN2B-containing NMDARs, and contextual fear memory, it provides a mechanistic framework for studying glia-dependent plasticity in hippocampal circuits.

• nor-Binaltorphimine Dihydrochloride Guide

  2026-08-22

  nor-Binaltorphimine dihydrochloride is a selective κ-opioid receptor antagonist for mechanistic opioid receptor signaling research. It provides a pharmacological way to interrogate KOR-linked pathways, but the 2024 mouse circuit study should not be treated as direct validation of this specific product.

• Multiomics of Crossbreeding and Goose Meat Quality

  2026-08-22

  Huang et al. used transcriptomics and nontargeted metabolomics to examine how crossbreeding and sex shape production traits and breast-muscle biology in Xingguo gray geese. The study connects carcass and meat-quality phenotypes with gene-expression and metabolite changes, providing a framework for interpreting heterosis through integrated molecular data.

• Metoprolol: Disease-Aware Beta1 Research Design

  2026-08-21

  Metoprolol is a selective beta1-adrenoceptor antagonist for mechanistic cardiovascular, inflammation, cancer, and angiogenesis research. This guide shows how disease-state pharmacokinetics and tissue exposure can improve assay design and interpretation.

8502 records 1/567 page Next 12345 下5页 Last page